Lund, Michael T
Novo Nordisk (Denmark)
4 papers on CoChatORCID 0000-0003-4512-3314
Most cited papers
- Verified
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
Enebo, L. B., Berthelsen, K. K., Kankam, M., Lund, M. T., Rubino, D. M., Satylganova, A., & Lau, D. C. W. (2021) · The Lancet
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 316
- Verified
Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial
Wadden, T. A., Tronieri, J. S., Sugimoto, D., Lund, M. T., Auerbach, P., Jensen, C., & Rubino, D. (2020) · Obesity
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 200
- Verified
High-intensity interval training improves insulin sensitivity in older individuals.
Søgaard, D., Lund, M. T., Scheuer, C. M., Dehlbæk, M. S., Dideriksen, S. G., Abildskov, C. V., Christensen, K. K., Dohlmann, T. L., Larsen, S., Vigelsø, A. H., et al. (2018) · Acta Physiologica
Cardiovascular and exercise physiologyPhysical Activity and Health
Cited by 98
- Verified
Adipose tissue mitochondrial respiration and lipolysis before and after a weight loss by diet and RYGB
Hansen, M., Lund, M. T., Gregers, E., Kraunsøe, R., Van Hall, G., Helge, J. W., & Dela, F. (2015) · Obesity
Bariatric Surgery and OutcomesAdipose Tissue and Metabolism
Cited by 57
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free